Cite

HARVARD Citation

    Laurent, L. et al. (2019). CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts. HPB. 21 (5), pp. 582-588. [Online]. 
  
Back to record